logo
#

Latest news with #Form8-K

The Generation Essentials Group and Black Spade Acquisition II Co Announce Approval of Business Combination by Black Spade II's Shareholders
The Generation Essentials Group and Black Spade Acquisition II Co Announce Approval of Business Combination by Black Spade II's Shareholders

Yahoo

timea day ago

  • Business
  • Yahoo

The Generation Essentials Group and Black Spade Acquisition II Co Announce Approval of Business Combination by Black Spade II's Shareholders

The Generation Essentials Group and Black Spade Acquisition II Co Expect to Close the Business Combination on June 3, 2025. TGE's Class A Ordinary Shares and Warrants are Expected to Be Listed on the New York Stock Exchange and NYSE American under Ticker Symbols "TGE" and "TGEWS", Respectively, Shortly After the Closing of the Business Combination, on a Date to be Announced. HONG KONG, May 30, 2025--(BUSINESS WIRE)--The Generation Essentials Group ("TGE") and Black Spade Acquisition II Co (NASDAQ: BSII) ("Black Spade II") today announced that their previously announced business combination (the "Business Combination") was approved at an extraordinary general meeting of Black Spade II's shareholders on May 30, 2025. Complete official results of the vote will be included in a current report on Form 8-K to be filed by Black Spade II with the U.S. Securities and Exchange Commission. The Business Combination is expected to close on June 3, 2025. Upon such closing, TGE will remain as the combined company, and its Class A ordinary shares and warrants are expected to be listed on the New York Stock Exchange and NYSE American under the ticker symbols "TGE" and "TGEWS", respectively, shortly thereafter, on a date to be announced. About The Generation Essentials Group (formerly known as World Media and Entertainment Universal Inc.) The Generation Essentials Group, jointly established by AMTD Group, AMTD IDEA Group (NYSE: AMTD; SGX: HKB) and AMTD Digital Inc. (NYSE: HKD), is headquartered in France and focuses on global strategies and developments in multi-media, entertainment, and cultural affairs worldwide as well as hospitality and VIP services. TGE comprises L'Officiel, The Art Newspaper, movie and entertainment projects, collectively a diversified media and entertainment portfolio of businesses, and a global portfolio of premium properties. About Black Spade Acquisition II Co Black Spade Acquisition II Co ("Black Spade II") is a blank check company incorporated for the purpose of effecting a business combination (Special Purpose Acquisition Company or SPAC). Listed on the Nasdaq, Black Spade II was founded by Black Spade Capital, which runs a global portfolio consisting of a wide spectrum of cross-border investments, and consistently seeks to add new investment projects and opportunities to its portfolio. Black Spade II is Black Spade Capital's second SPAC. Black Spade Capital's first SPAC completed its business combination with VinFast Auto Ltd., a Vietnamese electric vehicle company, in August 2023. At the time, it was the third largest ever de-SPAC by deal value (based on Dealogic data available through April 2024). View source version on Contacts Black Spade Acquisition II CoIR@ Sign in to access your portfolio

The Generation Essentials Group and Black Spade Acquisition II Co Announce Approval of Business Combination by Black Spade II's Shareholders
The Generation Essentials Group and Black Spade Acquisition II Co Announce Approval of Business Combination by Black Spade II's Shareholders

Business Wire

timea day ago

  • Business
  • Business Wire

The Generation Essentials Group and Black Spade Acquisition II Co Announce Approval of Business Combination by Black Spade II's Shareholders

HONG KONG--(BUSINESS WIRE)--The Generation Essentials Group ('TGE') and Black Spade Acquisition II Co (NASDAQ: BSII) ('Black Spade II') today announced that their previously announced business combination (the 'Business Combination') was approved at an extraordinary general meeting of Black Spade II's shareholders on May 30, 2025. Complete official results of the vote will be included in a current report on Form 8-K to be filed by Black Spade II with the U.S. Securities and Exchange Commission. The Business Combination is expected to close on June 3, 2025. Upon such closing, TGE will remain as the combined company, and its Class A ordinary shares and warrants are expected to be listed on the New York Stock Exchange and NYSE American under the ticker symbols 'TGE' and 'TGEWS', respectively, shortly thereafter, on a date to be announced. About The Generation Essentials Group (formerly known as World Media and Entertainment Universal Inc.) The Generation Essentials Group, jointly established by AMTD Group, AMTD IDEA Group (NYSE: AMTD; SGX: HKB) and AMTD Digital Inc. (NYSE: HKD), is headquartered in France and focuses on global strategies and developments in multi-media, entertainment, and cultural affairs worldwide as well as hospitality and VIP services. TGE comprises L'Officiel, The Art Newspaper, movie and entertainment projects, collectively a diversified media and entertainment portfolio of businesses, and a global portfolio of premium properties. About Black Spade Acquisition II Co Black Spade Acquisition II Co ('Black Spade II') is a blank check company incorporated for the purpose of effecting a business combination (Special Purpose Acquisition Company or SPAC). Listed on the Nasdaq, Black Spade II was founded by Black Spade Capital, which runs a global portfolio consisting of a wide spectrum of cross-border investments, and consistently seeks to add new investment projects and opportunities to its portfolio. Black Spade II is Black Spade Capital's second SPAC. Black Spade Capital's first SPAC completed its business combination with VinFast Auto Ltd., a Vietnamese electric vehicle company, in August 2023. At the time, it was the third largest ever de-SPAC by deal value (based on Dealogic data available through April 2024).

Virtu Financial Announces Transfer of Listing of Common Stock to the New York Stock Exchange
Virtu Financial Announces Transfer of Listing of Common Stock to the New York Stock Exchange

Yahoo

time2 days ago

  • Business
  • Yahoo

Virtu Financial Announces Transfer of Listing of Common Stock to the New York Stock Exchange

NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Virtu Financial, Inc. (NASDAQ: VIRT) ('Virtu Financial' or 'Virtu') a leading provider of global, multi-asset financial services that delivers liquidity and innovative, transparent products across the entire investment cycle to the global markets, today announced plans to transfer the listing of its Class A Common Stock ('Common Stock') to the New York Stock Exchange ('NYSE') from the Nasdaq Stock Market LLC. Virtu expects the listing of its Common Stock on Nasdaq to cease on June 16, 2025, and the listing of its Common Stock on the NYSE (NYSE: VIRT) to begin on June 17, 2025. 'We are excited to begin this next chapter of Virtu's journey on the New York Stock Exchange and we look forward to joining today's most respected and innovative companies on the world's largest stock exchange,' said Mr. Douglas A. Cifu, Chief Executive Officer of Virtu Financial. 'This move reflects our continued commitment to transparency, excellence, and long-term value creation for our shareholders. We look forward to deepening our relationships with investors and leveraging the NYSE's unique platform as we continue to grow and lead in global financial markets. We want to thank Nasdaq for the partnership and support they have provided since our initial public offering 10 years ago.' 'We are honored to welcome Virtu Financial to our community of innovators, entrepreneurs and market leaders at the New York Stock Exchange,' said Lynn Martin, President of NYSE Group. 'The deepest, most transparent and most liquid pool of capital that exists in this world is the U.S. capital market, and as a prominent liquidity provider, Virtu plays a critical role in the price formation process. Virtu has been a long and important partner to the NYSE over many years and we are thrilled to welcome them as an NYSE-listed company.' About Virtu Financial, is a leading provider of financial services and products that leverages cutting-edge technology to deliver liquidity to the global markets and innovative, transparent trading solutions to its clients. Leveraging its global market making expertise and infrastructure, Virtu provides a robust product suite including offerings in execution, liquidity sourcing, analytics and broker-neutral, multi-dealer platforms in workflow technology. Virtu's product offerings allow clients to trade on hundreds of venues across 50+ countries and in multiple asset classes, including global equities, ETFs, foreign exchange, futures, fixed income and myriad other commodities. In addition, Virtu's integrated, multi-asset analytics platform provides a range of pre- intra- and post-trade services, data products and compliance tools that clients rely upon to invest, trade and manage risk across global markets. Cautionary Note Regarding Forward-Looking StatementsThis Current Report on Form 8-K may contain 'forward-looking statements' made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including those related to the anticipated transfer of the primary listing of the Common Stock to the NYSE. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by which, such performance or results will be achieved. Virtu Financial assumes no obligation to update forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information, and if Virtu Financial does update one or more forward-looking statements, no inference should be drawn that it will make additional updates with respect thereto or with respect to other forward-looking statements. Forward-looking statements are based on information available at the time and/or management's good faith belief with respect to future events, and are subject to risks and uncertainties, some or all of which are not predictable or within Virtu Financial's control, that could cause actual performance or results to differ materially from those expressed in the statements. Those risks and uncertainties include, without limitation, risks relating to the anticipated transfer of the primary listing of the Common Stock to the NYSE. For a discussion of additional risks and uncertainties which could cause actual results to differ from those contained in forward-looking statements, see Virtu Financial's Securities and Exchange Commission (the 'SEC') filings, including but not limited to Virtu Financial's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K filed with the SEC. Contact: Investor Relations and Media RelationsAndrew Smithmedia@ in to access your portfolio

Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price
Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price

Yahoo

time2 days ago

  • Business
  • Yahoo

Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price

CHICAGO, May 29, 2025--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO) ("Cardio Diagnostics" or the "Company"), a pioneer in AI-powered precision cardiovascular medicine, today announced that on May 28, 2025, it received a notification letter (the "Notification Letter") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it had regained compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rule 5550(a)(2) ("Minimum Bid Requirement") for continued listing on The Nasdaq Capital Market. This was disclosed in the Company's Current Report on Form 8-K filed on May 28, 2025. The Nasdaq staff made this determination of compliance after the closing bid price of the Company's common stock traded above $1.00 per share from May 13, 2025, the date immediately following the Company's 1:30 reverse stock split having gone effective, through May 27, 2025. Accordingly, Nasdaq determined that the Company has regained compliance with Nasdaq's Minimum Bid Requirement, and that Nasdaq considered the matter closed. About Cardio Diagnostics Cardio Diagnostics is an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The Company was formed to further develop and commercialize clinical tests by leveraging a proprietary Artificial Intelligence (AI)-driven Integrated Genetic-Epigenetic Engine ("Core Technology") for cardiovascular disease to become one of the leading medical technology companies for improving prevention, detection, and treatment of cardiovascular disease. For more information, please visit Forward-Looking Statements Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will", "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, economic conditions, and dependence on results as discussed in the Annual Report on Form 10-K for the period ended December 31, 2024, under the heading "Risk Factors" in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release. View source version on Contacts Investors Investor Relations855-226-9991investors@ Media & Public Relations Public Relations855-226-9991pr@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price
Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price

Business Wire

time2 days ago

  • Business
  • Business Wire

Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price

CHICAGO--(BUSINESS WIRE)-- Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO) ('Cardio Diagnostics' or the 'Company'), a pioneer in AI-powered precision cardiovascular medicine, today announced that on May 28, 2025, it received a notification letter (the 'Notification Letter') from the Listing Qualifications Department of The Nasdaq Stock Market LLC ('Nasdaq') notifying the Company that it had regained compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rule 5550(a)(2) ('Minimum Bid Requirement') for continued listing on The Nasdaq Capital Market. This was disclosed in the Company's Current Report on Form 8-K filed on May 28, 2025. The Nasdaq staff made this determination of compliance after the closing bid price of the Company's common stock traded above $1.00 per share from May 13, 2025, the date immediately following the Company's 1:30 reverse stock split having gone effective, through May 27, 2025. Accordingly, Nasdaq determined that the Company has regained compliance with Nasdaq's Minimum Bid Requirement, and that Nasdaq considered the matter closed. About Cardio Diagnostics Cardio Diagnostics is an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The Company was formed to further develop and commercialize clinical tests by leveraging a proprietary Artificial Intelligence (AI)-driven Integrated Genetic-Epigenetic Engine ('Core Technology') for cardiovascular disease to become one of the leading medical technology companies for improving prevention, detection, and treatment of cardiovascular disease. For more information, please visit Forward-Looking Statements Certain statements and information included in this press release constitute 'forward-looking statements' within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases 'will', 'will likely result,' 'expected to,' 'will continue,' 'anticipated,' 'estimate,' 'projected,' 'intend,' 'goal,' or similar expressions are intended to identify 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, economic conditions, and dependence on results as discussed in the Annual Report on Form 10-K for the period ended December 31, 2024, under the heading 'Risk Factors' in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store